These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


450 related items for PubMed ID: 19084082

  • 21. Fenofibrate: treatment of hyperlipidemia and beyond.
    Rosenson RS.
    Expert Rev Cardiovasc Ther; 2008 Nov; 6(10):1319-30. PubMed ID: 19018684
    [Abstract] [Full Text] [Related]

  • 22. The metabolic syndrome: practical guide to origins and treatment: Part I.
    Wilson PW, Grundy SM.
    Circulation; 2003 Sep 23; 108(12):1422-4. PubMed ID: 14504251
    [No Abstract] [Full Text] [Related]

  • 23. [Metabolic syndrome: protective obesity].
    Nau JY.
    Rev Med Suisse; 2010 Mar 24; 6(241):644-5. PubMed ID: 20408371
    [No Abstract] [Full Text] [Related]

  • 24. [PPAR agonists do not come up to expectations. Hope about the preventive effect in type 2 diabetes has come to nought].
    Olsson AG.
    Lakartidningen; 2010 Mar 24; 103(35):2454-5. PubMed ID: 17002160
    [No Abstract] [Full Text] [Related]

  • 25. Increasing prevalence of obesity and clustered cardiometabolic risk: can treatment of the underlying cause reverse the trends?
    Ballantyne CM.
    Crit Pathw Cardiol; 2007 Jun 24; 6(2):41-5. PubMed ID: 17667863
    [Abstract] [Full Text] [Related]

  • 26. Cardiovascular outcomes for obesity and metabolic syndrome.
    Vega GL.
    Obes Res; 2002 Nov 24; 10 Suppl 1():27S-32S. PubMed ID: 12446855
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Therapy and clinical trials.
    Usman M, Peter R.
    Curr Opin Lipidol; 2006 Oct 24; 17(5):612-4. PubMed ID: 16960511
    [No Abstract] [Full Text] [Related]

  • 29. Targeting abdominal obesity and the metabolic syndrome to manage cardiovascular disease risk.
    Després JP.
    Heart; 2009 Jul 24; 95(13):1118-24. PubMed ID: 19525261
    [No Abstract] [Full Text] [Related]

  • 30. Cardiovascular risk in the spectrum of type 2 diabetes mellitus.
    Ahmed I, Goldstein BJ.
    Mt Sinai J Med; 2006 Sep 24; 73(5):759-68. PubMed ID: 17008936
    [Abstract] [Full Text] [Related]

  • 31. Obesity and cardiometabolic syndrome in children.
    Velasquez-Mieyer P, Neira CP, Nieto R, Cowan PA.
    Ther Adv Cardiovasc Dis; 2007 Oct 24; 1(1):61-81. PubMed ID: 19124396
    [Abstract] [Full Text] [Related]

  • 32. Fenofibrate set to benefit from new research on its active metabolite, fenofibric acid.
    Cardiovasc J Afr; 2008 Oct 24; 19(3):171-2. PubMed ID: 18568186
    [No Abstract] [Full Text] [Related]

  • 33. [Micronized fenofibrate and LDL-cholesterol subfractions].
    Soska V.
    Vnitr Lek; 1999 Jul 24; 45(7):441-3. PubMed ID: 11045166
    [Abstract] [Full Text] [Related]

  • 34. Reducing ocular damage in type 2 diabetes: the FIELD study shows fenofibrate benefits.
    Cardiovasc J Afr; 2007 Jul 24; 18(6):400. PubMed ID: 18092120
    [No Abstract] [Full Text] [Related]

  • 35. Clinical implications of the metabolic syndrome.
    Ceska R.
    Diab Vasc Dis Res; 2007 Sep 24; 4 Suppl 3():S2-4. PubMed ID: 17935057
    [Abstract] [Full Text] [Related]

  • 36. Management of metabolic syndrome in children and adolescents.
    Pacifico L, Anania C, Martino F, Poggiogalle E, Chiarelli F, Arca M, Chiesa C.
    Nutr Metab Cardiovasc Dis; 2011 Jun 24; 21(6):455-66. PubMed ID: 21565479
    [Abstract] [Full Text] [Related]

  • 37. Unmet needs in controlling metabolic disease.
    Haffner SM.
    Rev Cardiovasc Med; 2007 Jun 24; 8 Suppl 4():S17-24. PubMed ID: 17934390
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Beyond LDL cholesterol: the role of elevated triglycerides and low HDL cholesterol in residual CVD risk remaining after statin therapy.
    Alagona P.
    Am J Manag Care; 2009 Mar 24; 15(3 Suppl):S65-73. PubMed ID: 19355805
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 23.